Pharmaceutical giant Johnson & Johnson has plans to begin testing its coronavirus vaccine on children, according to Reuters.
Reuters reported on Friday the company soon plans to test the experimental vaccine candidate on people aged 12 to 18.
Our country is in a historic fight against the Coronavirus. Add Changing America to your Facebook or Twitter feed to stay on top of the news.
“We plan to go into children as soon as we possibly can, but very carefully in terms of safety,” Jerald Sadoff, senior advisor with Johnson & Johnson’s vaccine division, said during a meeting held by the Centers for Disease Control and Prevention (CDC) Friday, according to Reuters.
Sadoff said the company also has plans to test the vaccine in children younger than 12 if it’s shown to be safe among those 12 to 18.
Most COVID-19 vaccine trials are focused on whether the shots are safe and effective in adults. Pfizer, which has manufactured one of the four vaccine candidates currently in phase three trials in the U.S., recently started testing its vaccine candidate in children.